Items where Author is "Neumann, S."
![]() | Up a level |
Article
Goekbuget, N. and Topp, M. S. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE IN ADULT PATIENTS WITH RELAPSED B-PRECURSOR ALL: UPDATED RESULTS OF AN ONGOING PHASE II TRIAL. ANNALS OF ONCOLOGY, 23 (Suppl1). i20-i21. ISSN 0923-7534
Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H-A and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M-E and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) Anti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor ALL. ONKOLOGIE, 35 (suppl6). p. 186. ISSN 0378-584X
Topp, M. S. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. -A and Reichle, A. and Marks, R. and Klappers, P. and Mergen, N. and Nagorsen, D. and Kufer, P. and Goebeler, M. -E and Einsele, H. and Hoelzer, D. and Bargou, R. (2011) Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study. ONKOLOGIE, 34 (Suppl6). p. 16. ISSN 0378-584X
Conference or Workshop Item
Neumann, S. and Rosentritt, M. and Behr, M. and Handel, G. (2003) Marginal adaptation of three-unit alloy FPDs with different cements. In: 81st General Session of the IADR - 2nd Meeting of the PEF (Bristish, Continental European, Irish, and Scandinavian Divisions of the IADR), June 25-28, 2003, Goeteborg, Sweden.
Other
Banas, M. and Neumann, S. and Eiglsperger, J. and Pagel, P. and Chittka, D. and Banas, B. (2017) DETECTION OF ACUTE CELLULAR RENAL ALLOGRAFT REJECTION VIA URINE METABOLITES - THE RENALTX-SCORE-U100. WILEY, HOBOKEN.
Banas, M. and Pagel, P. and Neumann, S. and Krumpel, A. and Eiglsperger, J. and Chittka, D. and Kraemer, B. and Banas, B. (2015) NON-INVASIVE MONITORING OF RENAL ALLOGRAFT FUNCTION BY NMR-BASED URINE METABOLOMICS. WILEY-BLACKWELL, HOBOKEN.
Topp, M. S. and Goebeler, M-E and Einsele, H. and Bargou, R. and Goekbuget, N. and Zugmaier, G. and Mergen, N. and Klappers, P. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. A. and Bruegge-mann, M. and Ritgen, M. and Reichle, A. and Marks, R. and Faul, C. (2013) ANTI-CD19 BITE (R) BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE AND LONG OVERALL SURVIVAL IN ADULT PATIENTS WITH RELAPSED/REFRACTORY B-PRECURSOR ALL. SPRINGER, NEW YORK.
Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. A. and Reichle, A. and Marks, R. and Faul, C. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. -E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2013) Anti-CD19 BiTE (R) blinatumomab induces high complete remission rates in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL) including relapse after stem cell transplantation (SCT). NATURE PUBLISHING GROUP, LONDON.
["eprint_typename_meeting" not defined]
Banas, M. and Neumann, S. and Pagel, P. and Chittka, D. and Pfahlert, V. and Banas, B. (2018) Non-Invasive Diagnostic of Renal Allograft Rejection via Urine Metabolites Using NMR-Spectroscopy. [["eprint_typename_meeting" not defined]]

